Case: A Case of Pembrolizumab Induced Myocarditis and Complete Heart Block

Case: A Case of Pembrolizumab Induced Myocarditis and Complete Heart Block

Use of checkpoint inhibitor pembrolizumab has continued to grow since its approval in 2014. Rare instances of conduction side effects have been described including brady and tachyarrhythmias, heart block and even cardiac arrest. We present a case of Pembrolizumab induced myocarditis and persistent t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of community hospital internal medicine perspectives 2024-05, Vol.14 (3), p.77
Hauptverfasser: Adhikari, Janak, Sharma, Priyadarshani, Karnabi, Eddy, Merchan, Juan H, Arshad, Hasnain
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 3
container_start_page 77
container_title Journal of community hospital internal medicine perspectives
container_volume 14
creator Adhikari, Janak
Sharma, Priyadarshani
Karnabi, Eddy
Merchan, Juan H
Arshad, Hasnain
description Use of checkpoint inhibitor pembrolizumab has continued to grow since its approval in 2014. Rare instances of conduction side effects have been described including brady and tachyarrhythmias, heart block and even cardiac arrest. We present a case of Pembrolizumab induced myocarditis and persistent third-degree heart block.
doi_str_mv 10.55729/2000-9666.1329
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3083220117</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3083220117</sourcerecordid><originalsourceid>FETCH-LOGICAL-c222t-6efcc651207cf8150d08cf3f8d13ead2390ee39a3baf4074a2f06bfa0391e4df3</originalsourceid><addsrcrecordid>eNpNkL1PwzAQxS0EolXpzIY8sqQ92_lkKxXQoiIYYLYc-ywFkrrYyVD-ehIKFdO7O717evoRcslgliQZL-YcAKIiTdMZE7w4IePj4fTfPCLTEN77DVKexSDOyUgUINIkF2PyuFQBb-iCDkqdpS_YlN7V1VfXqJKut6bTaOjT3mnlTdVWgaqtoUvX7Gpska5Q-Zbe1k5_XJAzq-qA01-dkLf7u9flKto8P6yXi02kOedtlKLVOk0Yh0zbnCVgINdW2NwwgcrwvhuiKJQolY0hixW3kJZWgSgYxsaKCbk-5O68--wwtLKpgsa6Vlt0XZACcsE5MJb11vnBqr0LwaOVO181yu8lA_nDUA6Y5IBJDgz7j6vf8K5s0Bz9f8TENzpHaoU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3083220117</pqid></control><display><type>article</type><title>Case: A Case of Pembrolizumab Induced Myocarditis and Complete Heart Block</title><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Adhikari, Janak ; Sharma, Priyadarshani ; Karnabi, Eddy ; Merchan, Juan H ; Arshad, Hasnain</creator><creatorcontrib>Adhikari, Janak ; Sharma, Priyadarshani ; Karnabi, Eddy ; Merchan, Juan H ; Arshad, Hasnain</creatorcontrib><description>Use of checkpoint inhibitor pembrolizumab has continued to grow since its approval in 2014. Rare instances of conduction side effects have been described including brady and tachyarrhythmias, heart block and even cardiac arrest. We present a case of Pembrolizumab induced myocarditis and persistent third-degree heart block.</description><identifier>ISSN: 2000-9666</identifier><identifier>EISSN: 2000-9666</identifier><identifier>DOI: 10.55729/2000-9666.1329</identifier><identifier>PMID: 39036583</identifier><language>eng</language><publisher>United States</publisher><ispartof>Journal of community hospital internal medicine perspectives, 2024-05, Vol.14 (3), p.77</ispartof><rights>2024 Greater Baltimore Medical Center.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39036583$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Adhikari, Janak</creatorcontrib><creatorcontrib>Sharma, Priyadarshani</creatorcontrib><creatorcontrib>Karnabi, Eddy</creatorcontrib><creatorcontrib>Merchan, Juan H</creatorcontrib><creatorcontrib>Arshad, Hasnain</creatorcontrib><title>Case: A Case of Pembrolizumab Induced Myocarditis and Complete Heart Block</title><title>Journal of community hospital internal medicine perspectives</title><addtitle>J Community Hosp Intern Med Perspect</addtitle><description>Use of checkpoint inhibitor pembrolizumab has continued to grow since its approval in 2014. Rare instances of conduction side effects have been described including brady and tachyarrhythmias, heart block and even cardiac arrest. We present a case of Pembrolizumab induced myocarditis and persistent third-degree heart block.</description><issn>2000-9666</issn><issn>2000-9666</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpNkL1PwzAQxS0EolXpzIY8sqQ92_lkKxXQoiIYYLYc-ywFkrrYyVD-ehIKFdO7O717evoRcslgliQZL-YcAKIiTdMZE7w4IePj4fTfPCLTEN77DVKexSDOyUgUINIkF2PyuFQBb-iCDkqdpS_YlN7V1VfXqJKut6bTaOjT3mnlTdVWgaqtoUvX7Gpska5Q-Zbe1k5_XJAzq-qA01-dkLf7u9flKto8P6yXi02kOedtlKLVOk0Yh0zbnCVgINdW2NwwgcrwvhuiKJQolY0hixW3kJZWgSgYxsaKCbk-5O68--wwtLKpgsa6Vlt0XZACcsE5MJb11vnBqr0LwaOVO181yu8lA_nDUA6Y5IBJDgz7j6vf8K5s0Bz9f8TENzpHaoU</recordid><startdate>20240507</startdate><enddate>20240507</enddate><creator>Adhikari, Janak</creator><creator>Sharma, Priyadarshani</creator><creator>Karnabi, Eddy</creator><creator>Merchan, Juan H</creator><creator>Arshad, Hasnain</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20240507</creationdate><title>Case: A Case of Pembrolizumab Induced Myocarditis and Complete Heart Block</title><author>Adhikari, Janak ; Sharma, Priyadarshani ; Karnabi, Eddy ; Merchan, Juan H ; Arshad, Hasnain</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c222t-6efcc651207cf8150d08cf3f8d13ead2390ee39a3baf4074a2f06bfa0391e4df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Adhikari, Janak</creatorcontrib><creatorcontrib>Sharma, Priyadarshani</creatorcontrib><creatorcontrib>Karnabi, Eddy</creatorcontrib><creatorcontrib>Merchan, Juan H</creatorcontrib><creatorcontrib>Arshad, Hasnain</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of community hospital internal medicine perspectives</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Adhikari, Janak</au><au>Sharma, Priyadarshani</au><au>Karnabi, Eddy</au><au>Merchan, Juan H</au><au>Arshad, Hasnain</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Case: A Case of Pembrolizumab Induced Myocarditis and Complete Heart Block</atitle><jtitle>Journal of community hospital internal medicine perspectives</jtitle><addtitle>J Community Hosp Intern Med Perspect</addtitle><date>2024-05-07</date><risdate>2024</risdate><volume>14</volume><issue>3</issue><spage>77</spage><pages>77-</pages><issn>2000-9666</issn><eissn>2000-9666</eissn><abstract>Use of checkpoint inhibitor pembrolizumab has continued to grow since its approval in 2014. Rare instances of conduction side effects have been described including brady and tachyarrhythmias, heart block and even cardiac arrest. We present a case of Pembrolizumab induced myocarditis and persistent third-degree heart block.</abstract><cop>United States</cop><pmid>39036583</pmid><doi>10.55729/2000-9666.1329</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2000-9666
ispartof Journal of community hospital internal medicine perspectives, 2024-05, Vol.14 (3), p.77
issn 2000-9666
2000-9666
language eng
recordid cdi_proquest_miscellaneous_3083220117
source PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central
title Case: A Case of Pembrolizumab Induced Myocarditis and Complete Heart Block
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T17%3A14%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Case:%20A%20Case%20of%20Pembrolizumab%20Induced%20Myocarditis%20and%20Complete%20Heart%20Block&rft.jtitle=Journal%20of%20community%20hospital%20internal%20medicine%20perspectives&rft.au=Adhikari,%20Janak&rft.date=2024-05-07&rft.volume=14&rft.issue=3&rft.spage=77&rft.pages=77-&rft.issn=2000-9666&rft.eissn=2000-9666&rft_id=info:doi/10.55729/2000-9666.1329&rft_dat=%3Cproquest_cross%3E3083220117%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3083220117&rft_id=info:pmid/39036583&rfr_iscdi=true